search
Back to results

Nutritional Intervention With Black Garlic

Primary Purpose

Hypercholesterolemia, Hypertension, Hyperlipidemias

Status
Unknown status
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
black garlic
Sponsored by
Maria Pilar Zafrilla Rentero
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Hypercholesterolemia focused on measuring black garlic, sulphur bioactive compounds, hypercholesterolemia, hyperlipemia, inflammation, endothelial dysfunction

Eligibility Criteria

40 Years - 65 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

Healthy Group:

  • Total blood cholesterol levels of less than 200 mg/dL
  • LDL-cholesterol levels of less than 135 mg/dL
  • Not suffer from any other pathology.
  • No drugs, hormones or dietary supplements, no smoking, no pregnancy, no vegetarianism, etc.

Cardiovascular Risk Group:

  • Total cholesterol levels between 200-300 mg/dL
  • LDL-cholesterol levels between 135-175 mg/dL.
  • No acute or chronic pathology, except hypercholesterolemia
  • No drugs, hormones or dietary supplements, no smoking, no pregnancy, no vegetarianism, etc.).

Exclusion Criteria:

  • Failure to meet any of the inclusion criteria

Sites / Locations

  • Universidad Católica de Murcia (UCAM)

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Healthy Group,

Hypercholesterolemia

Arm Description

Daily consumption of 4 cloves of black garlic, not cooked, during 12 weeks

Daily consumption of 4 cloves of black garlic, not cooked, during 12 weeks

Outcomes

Primary Outcome Measures

Impact on blood pressure
Blood pressure (diastolic, systolic)
Impact on lipid profile
Plasma levels of total cholesterol, HDL, LDL, VLDL (very low-density lipoprotein), triglycerides, apolipoproteins A1 and B.

Secondary Outcome Measures

Impact on blood cells (Hematology)
Blood counts
evaluation of liver function to determine product safety
Hepatic enzymes (GOT, GPT)
Changes in cytokine levels
Plasma levels of pro-inflammatory: IL-1β, IL6 , TNF-α (tumor necrosis factor) and anti-inflammatory (IL-10, IL-17) cytokines.
Changes in chemokine MCP-1 (monocyte chemotactic protein)
Plasma levels of chemokine MCP-1
Changes in C reactive protein
Plasma levels of C reactive protein
Impact on endothelial function
Plasma levels of nitric oxide, adhesion molecules VCAM-1 (vascular endothelial cell adhesion molecule), ICAM-1 (intercellular adhesion molecule), chemokines as markers of endothelium (E-selectin) and platelet (P-selectin) activation.
Impact on glucose levels
Plasma levels of glucose
Impact on glycosylated hemoglobin (HbA1c)
Plasma levels of glycosylated hemoglobin
Impact in hormones related to metabolism
Plasma levels of thyroid hormones (TSH, T3, T4).

Full Information

First Posted
June 8, 2021
Last Updated
October 15, 2021
Sponsor
Maria Pilar Zafrilla Rentero
Collaborators
Instituto de Investigación y formación agraria y pesquera (IFAPA)
search

1. Study Identification

Unique Protocol Identification Number
NCT05082350
Brief Title
Nutritional Intervention With Black Garlic
Official Title
Clinical Trial to Evaluate the Efficacy of Black Garlic in Reducing Cardiovascular Risk in Subjects With Hypercholesterolemia
Study Type
Interventional

2. Study Status

Record Verification Date
October 2021
Overall Recruitment Status
Unknown status
Study Start Date
September 1, 2020 (Actual)
Primary Completion Date
June 30, 2021 (Actual)
Study Completion Date
November 30, 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Maria Pilar Zafrilla Rentero
Collaborators
Instituto de Investigación y formación agraria y pesquera (IFAPA)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
A controlled clinical intervention study is proposed to determine the effect of black garlic consumption on biomarkers of cardiovascular function and associated pathologies in a healthy population at risk for cardiovascular disease. Black garlic is the result of a fermentation process of common white garlic in which the temperature and humidity are kept constant over a long period of time. Black garlic is particularly rich in phenolic compounds such as S-allylcysteine or S-allyl-mercaptocysteine, with antioxidant action. It also provides vitamin C and other valuable antioxidant substances such as flavonoids.
Detailed Description
A parallel, controlled clinical trial will be performed to assess the effect of garlic on mild hypercholesterolemia. The study will conducted in two groups of volunteer: healthy and at cardiovascular risk (hypercholesterolemic subjects), consuming black garlic, with each individual acting as its own control. The study will have a total duration of 18 weeks, divided in two stages: Stage 1: basal or washout stage of 2 weeks, in which volunteer follow their usual diet with restrictions Stage 2: intervention stage of 16 weeks, in which volunteer consume black garlic Sixty healthy volunteers (men and women) between 40-65 years old and BMI between 24.9-29.9 kg/m2 will be recruited. From the total of volunteer, 30 will correspond to the Healthy Group, which should have total blood cholesterol levels less than 200 mg/dL and LDL-cholesterol less than 135 mg/dL. The other 30 volunteers correspond to the Cardiovascular Risk Group, which should have total cholesterol levels between 200-300 mg/dL and LDL-cholesterol levels between 135-175 mg/dL. Other inclusion criteria established for all volunteers are: no acute or chronic pathology, (except hypercholesterolemia for the risk group), no taking drugs, hormones or dietary supplements, no smoking, no pregnancy, no vegetarianism. The study has been approved by the Ethical Committee of Catholic University of Murcia (UCAM) and will be carried out in accordance with the Helsinki Declaration of Human Studies. Recruitment will take place at various Health Centers and at UCAM. All participants will be informed on the characteristics of the study and, after signing the informed consent, a routine analysis will be requested to classify the volunteer in the healthy or cardiovascular risk group. To avoid bias due to gender, the number of women and men recruited in both groups will be balanced. The size of the study population has been estimated taking total blood cholesterol level as the main variable and taking into account that the study design is randomized and parallel. Considering a statistical power of 80%, a statistical significance level of 5% (one tail), a standard deviation of 6.5, aiming to estimate a difference of 2.5, the number of volunteers required is 25 for each group, rising to 30 in anticipation of dropouts. This number, being two study groups, will allow obtaining results with statistical significance in other biochemical parameters that would be determined as secondary variables of the study and that would inform on the effect of black garlic consumption on cardiovascular function and associated dysfunctions (inflammation, hypertension, endothelial function, diabetes, etc.). After an initial washout (basal) stage common to all groups, in which the volunteers will consume their usual diet with restriction in the consumption of fresh garlic and garlic products, the intervention will start, with the consumption of black garlic for 12 weeks. Volunteers will be provided with black garlic and they will ensure that no other type of garlic or culinary seasoning is used. Dietary and physical activity questionnaire according to the "Global Physical Activity Questionnarie (GPAQ)" will be compiled in order to collect information on habits and lifestyle, as well as to ensure the compliance of food restrictions. During the study, visits will be scheduled on the first day and last day of each stage. The subjects will come to the Unit on fasting conditions and will provide the first morning urine. Blood sample will be taken, plasma aliquoted and stored at -80°C until analysis.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypercholesterolemia, Hypertension, Hyperlipidemias, Inflammation, Endothelial Dysfunction
Keywords
black garlic, sulphur bioactive compounds, hypercholesterolemia, hyperlipemia, inflammation, endothelial dysfunction

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
A controlled clinical intervention study is proposed to determine the effect of black garlic consumption on biomarkers of cardiovascular function and associated pathologies in a healthy population at risk for cardiovascular disease.
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
62 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Healthy Group,
Arm Type
Experimental
Arm Description
Daily consumption of 4 cloves of black garlic, not cooked, during 12 weeks
Arm Title
Hypercholesterolemia
Arm Type
Experimental
Arm Description
Daily consumption of 4 cloves of black garlic, not cooked, during 12 weeks
Intervention Type
Dietary Supplement
Intervention Name(s)
black garlic
Intervention Description
Daily consumption of 4 cloves of black garlic, not cooked, during 12 weeks
Primary Outcome Measure Information:
Title
Impact on blood pressure
Description
Blood pressure (diastolic, systolic)
Time Frame
changes observed from baseline at day 0 compared to 12 weeks.
Title
Impact on lipid profile
Description
Plasma levels of total cholesterol, HDL, LDL, VLDL (very low-density lipoprotein), triglycerides, apolipoproteins A1 and B.
Time Frame
changes observed from baseline at day 0 compared to 12 weeks.
Secondary Outcome Measure Information:
Title
Impact on blood cells (Hematology)
Description
Blood counts
Time Frame
changes observed from baseline at day 0 compared to 12 weeks.
Title
evaluation of liver function to determine product safety
Description
Hepatic enzymes (GOT, GPT)
Time Frame
changes observed from baseline at day 0 compared to 12 weeks.
Title
Changes in cytokine levels
Description
Plasma levels of pro-inflammatory: IL-1β, IL6 , TNF-α (tumor necrosis factor) and anti-inflammatory (IL-10, IL-17) cytokines.
Time Frame
changes observed from baseline at day 0 compared to 12 weeks.
Title
Changes in chemokine MCP-1 (monocyte chemotactic protein)
Description
Plasma levels of chemokine MCP-1
Time Frame
changes observed from baseline at day 0 compared to 12 weeks.
Title
Changes in C reactive protein
Description
Plasma levels of C reactive protein
Time Frame
changes observed from baseline at day 0 compared to 12 weeks.
Title
Impact on endothelial function
Description
Plasma levels of nitric oxide, adhesion molecules VCAM-1 (vascular endothelial cell adhesion molecule), ICAM-1 (intercellular adhesion molecule), chemokines as markers of endothelium (E-selectin) and platelet (P-selectin) activation.
Time Frame
changes observed from baseline at day 0 compared to 12 weeks.
Title
Impact on glucose levels
Description
Plasma levels of glucose
Time Frame
changes observed from baseline at day 0 compared to 12 weeks.
Title
Impact on glycosylated hemoglobin (HbA1c)
Description
Plasma levels of glycosylated hemoglobin
Time Frame
changes observed from baseline at day 0 compared to 12 weeks.
Title
Impact in hormones related to metabolism
Description
Plasma levels of thyroid hormones (TSH, T3, T4).
Time Frame
changes observed from baseline at day 0 compared to 12 weeks.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Healthy Group: Total blood cholesterol levels of less than 200 mg/dL LDL-cholesterol levels of less than 135 mg/dL Not suffer from any other pathology. No drugs, hormones or dietary supplements, no smoking, no pregnancy, no vegetarianism, etc. Cardiovascular Risk Group: Total cholesterol levels between 200-300 mg/dL LDL-cholesterol levels between 135-175 mg/dL. No acute or chronic pathology, except hypercholesterolemia No drugs, hormones or dietary supplements, no smoking, no pregnancy, no vegetarianism, etc.). Exclusion Criteria: Failure to meet any of the inclusion criteria
Facility Information:
Facility Name
Universidad Católica de Murcia (UCAM)
City
Murcia
ZIP/Postal Code
30107
Country
Spain

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Nutritional Intervention With Black Garlic

We'll reach out to this number within 24 hrs